H4COVID

Ongoing study

Official Study Title
Hydrogen Sulfate guided therapy with STS for COVID-19 patients in need of Critical Care: The H4COVID open-label, randomized, triple-arm trial

Brief Description

H4COVID open-label study is aiming to describe the safety of administration of three doses of STS to critically ill patients with confirmed COVID-19.

Details
Status: Recruiting
Study Type: Interventional (Clinical Trial)
Study phase: II
Study sites: 1 site in Greece
Target of enrolment: 30 participants

ClinicalTrials.gov Identifier: NCT05277285
EudraCT number: 2022-000642-16
National Organization for Medicines Approval: IS026-22
National Ethics Committee Approval: 20/22

Study Start: April 2022

Condition/Disease studied: COVID-19; Virus Diseases; Corona Virus Infection
Keywords: COVID-19; SARS-CoV-2; Hydrogen Sulfide; Sodium Thiosulfate; Hydrogen Sulfide donor